- CME's newest derivatives product would allow a broader range of investors to participate in the cryptocurrency market.
- Micro Bitcoin futures recently launched by the exchange giant would be a more cost-effective method for traders to fine-tune their BTC exposure.
- The growing demand and the surging price of the leading cryptocurrency were cited as the main drivers for introducing this new product.
The Chicago Mercantile Exchange (CME) has launched a new futures product targeting retail investors as demand for Bitcoin continues to grow at an exponential rate.
Fueling crypto adoption by lowering entry barrier
The new micro Bitcoin futures contract by CME will be one-tenth the size of a Bitcoin, providing a more cost-effective entry for market participants. The new cryptocurrency derivatives product could open the door to wider mainstream adoption of the new asset class.
Worth 0.1 BTC, the micro Bitcoin futures contract could give traders an additional tool to hedge their cryptocurrency risks. According to JB Mackenzie, managing director of TD Ameritrade Futures and Forex, micro Bitcoin futures could solve two main issues with investing in cryptocurrencies.
The two critical entry barriers are the “high cost and the desire to engage within a regulated environment,” affirmed Mackenzie.
Since the launch of CME’s Bitcoin futures contract in late 2017, the cryptocurrency derivatives industry has grown exponentially. In December 2020, crypto derivatives trades made up 55% of the overall market.
Asset management giant BlackRock also previously revealed that it had purchased Bitcoin futures from CME.
In late March, CME first announced its intent to launch a micro Bitcoin derivatives product, citing the growing demand for smaller contracts. Tim McCourt, CME Group global head of equity index and alternative investment products, said:
We are pleased to introduce this new contract at a time when we continue to see a consistent growth of liquidity and participation in our crypto futures and options.
In an earnings call, Sean Tully, senior managing director and global head-financial and OTC products at CME, noted that the first-quarter revenue from Bitcoin futures offering was higher than the entirety of 2020, which was about $4.7 million. He added that Q1 was positive and much more robust than in the past. Tully expects a wider customer base for the new derivatives product.
CME micro Bitcoin futures contract launched on May 3. Brooks Dudley, global head of digital assets at ED&F Man Capital Markets, said:
We executed the first block trade of 140 lots for two of our clients – Genesis Trading and XBTO. These smaller right-sized CME micro Bitcoin futures contracts will make crypto futures trading more accessible for traders of all sizes.
The micro BTC futures are cash-settled, based on the CME CF Bitcoin Reference Rate.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.